Skip to main content
Toggle navigation
Login
Search
Home
Back
Favorite
0
Like
Facebook
Tweet
Print
Session 1: Lymphoma
What’s New In Therapy For Hodgkin And T Cell Lymphoma
Friday, April 22, 2022
9:20 AM – 9:40 AM
Speaker(s)
Jia Ruan, MD, PhD
Professor of Clinical Medicine
Weill Cornell Medicine
New York, New York
Learning Objectives:
Compare clinical safety and efficacy data of new and emerging ADC therapies for hematological malignancies
Determine appropriate candidates and sequencing for ADC therapy in hematological malignancies
Understand how to manage common AEs and DDIs associated with ADC therapy in hematological malignancies